Tandem Diabetes Care (TNDM) Competitors $16.85 +0.08 (+0.48%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TNDM vs. INSP, BLCO, SLNO, IRTC, TMDX, PRCT, NVST, LMAT, LIVN, and ENOVShould you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), LivaNova (LIVN), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. Tandem Diabetes Care vs. Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular LivaNova Enovis Inspire Medical Systems (NYSE:INSP) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, community ranking, earnings, risk and media sentiment. Does the MarketBeat Community favor INSP or TNDM? Tandem Diabetes Care received 392 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. However, 61.71% of users gave Inspire Medical Systems an outperform vote while only 60.89% of users gave Tandem Diabetes Care an outperform vote. CompanyUnderperformOutperformInspire Medical SystemsOutperform Votes19561.71% Underperform Votes12138.29% Tandem Diabetes CareOutperform Votes58760.89% Underperform Votes37739.11% Which has preferable valuation & earnings, INSP or TNDM? Inspire Medical Systems has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M5.87$53.51M$1.7391.58Tandem Diabetes Care$940.20M1.19-$222.61M-$1.46-11.54 Which has more risk and volatility, INSP or TNDM? Inspire Medical Systems has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.52, suggesting that its stock price is 52% more volatile than the S&P 500. Does the media prefer INSP or TNDM? In the previous week, Tandem Diabetes Care had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 17 mentions for Tandem Diabetes Care and 14 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.45 beat Tandem Diabetes Care's score of 1.44 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 12 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tandem Diabetes Care 10 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer INSP or TNDM? Inspire Medical Systems currently has a consensus target price of $218.90, suggesting a potential upside of 38.17%. Tandem Diabetes Care has a consensus target price of $43.81, suggesting a potential upside of 160.01%. Given Tandem Diabetes Care's higher probable upside, analysts clearly believe Tandem Diabetes Care is more favorable than Inspire Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70Tandem Diabetes Care 0 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.53 Do insiders and institutionals have more ownership in INSP or TNDM? 94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 1.9% of Tandem Diabetes Care shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is INSP or TNDM more profitable? Inspire Medical Systems has a net margin of 6.67% compared to Tandem Diabetes Care's net margin of -14.84%. Inspire Medical Systems' return on equity of 8.19% beat Tandem Diabetes Care's return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems6.67% 8.19% 7.09% Tandem Diabetes Care -14.84%-44.19%-11.99% SummaryInspire Medical Systems beats Tandem Diabetes Care on 12 of the 18 factors compared between the two stocks. Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNDM vs. The Competition Export to ExcelMetricTandem Diabetes CareSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.12B$4.38B$5.57B$7.82BDividend YieldN/A39.98%5.11%4.22%P/E Ratio-8.7330.6522.4418.48Price / Sales1.1954.19394.66103.91Price / CashN/A51.0838.1834.62Price / Book3.506.116.774.25Net Income-$222.61M$68.15M$3.22B$248.23M7 Day Performance1.42%1.33%3.09%3.29%1 Month Performance-12.60%-4.28%-0.14%2.43%1 Year Performance-54.07%24.22%17.98%5.54% Tandem Diabetes Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNDMTandem Diabetes Care4.6589 of 5 stars$16.85+0.5%$43.81+160.0%-54.1%$1.12B$940.20M-8.732,600News CoveragePositive NewsINSPInspire Medical Systems4.8542 of 5 stars$144.74-3.6%$218.90+51.2%-34.4%$4.31B$802.80M83.67760Upcoming EarningsBLCOBausch + Lomb3.8397 of 5 stars$12.05-0.1%$18.82+56.2%-20.4%$4.26B$4.79B-13.2412,500Earnings ReportNews CoverageGap DownSLNOSoleno Therapeutics4.6454 of 5 stars$68.93-1.5%$99.63+44.5%+67.6%$3.16BN/A-20.7630Upcoming EarningsPositive NewsGap DownIRTCiRhythm Technologies0.9754 of 5 stars$98.63-2.3%$119.73+21.4%-2.5%$3.10B$591.84M-27.101,790News CoveragePositive NewsTMDXTransMedics Group3.0328 of 5 stars$87.72-0.6%$122.70+39.9%-2.3%$2.97B$441.54M93.32210Analyst ForecastGap DownPRCTPROCEPT BioRobotics2.7239 of 5 stars$53.43+0.8%$91.43+71.1%+1.9%$2.93B$224.50M-27.40430Earnings ReportAnalyst RevisionPositive NewsHigh Trading VolumeNVSTEnvista4.4284 of 5 stars$14.88-2.0%$19.96+34.2%-18.3%$2.56B$2.51B-2.2912,700Analyst ForecastLMATLeMaitre Vascular2.1696 of 5 stars$84.72-1.8%$95.25+12.4%+40.0%$1.91B$219.86M46.30490Upcoming EarningsPositive NewsLIVNLivaNova3.8183 of 5 stars$34.61-2.7%$61.17+76.7%-33.6%$1.88B$1.25B82.402,900Upcoming EarningsPositive NewsENOVEnovis2.7286 of 5 stars$32.25+0.9%$58.50+81.4%-37.4%$1.84B$2.11B-14.736,800Upcoming EarningsPositive News Related Companies and Tools Related Companies INSP Alternatives BLCO Alternatives SLNO Alternatives IRTC Alternatives TMDX Alternatives PRCT Alternatives NVST Alternatives LMAT Alternatives LIVN Alternatives ENOV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNDM) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TNDM Stock Free TNDM Stock Alerts